Patents by Inventor Michael Horlington

Michael Horlington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions
    Patent number: 4425346
    Abstract: The present invention relates to pharmaceutical compositions adapted for topical administration to the eye and to their preparation and use. More specifically this invention relates to anti-glaucoma ophthalmic compositions containing tetraazabicyclic compounds of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, X and Y are hereinafter defined and to the preparation and use of such compositions.
    Type: Grant
    Filed: January 25, 1982
    Date of Patent: January 10, 1984
    Assignee: Smith and Nephew Associated Companies Limited
    Inventor: Michael Horlington
  • Compositions for the treatment of glaucoma containing triamterene
    Patent number: 4425344
    Abstract: A sterile, non-irritant, non-toxic pharmaceutical composition adapted for topical administration to the eye which contains 2,4,7-triamino-6-phenylpteridine is described. The composition may be used to treat ocular hypertension and glaucoma.
    Type: Grant
    Filed: July 27, 1981
    Date of Patent: January 10, 1984
    Assignee: Smith and Nephew Associated Companies Limited
    Inventor: Michael Horlington
  • Pharmaceutical composition containing triamterene
    Patent number: 4425345
    Abstract: A sterile, non-irritant, non-toxic aqueous solution adapted for topical administration to the eye which contains 2,4,7-triamino-6-phenylpteridine rendered soluble by a solubilizing amount of a xanthine derivative. The composition may be used to treat ocular hypertension and glaucoma.
    Type: Grant
    Filed: December 8, 1981
    Date of Patent: January 10, 1984
    Assignee: Smith and Nephew Associated Companies Limited
    Inventors: Michael Horlington, Lindsey V. Scott